Understand Diagnostic Market

Build Diagnostic Plan

Implement Diagnostic Plan

Diagnostic Tracking

New projects launched this month

Ovarian cancer lab tracking in US
Lab mapping and implementation in Italy
Hematology lab operations project in US
BRAF lab operations in EU
Epilepsy commercialization planning in US
FGFR CDx landscape planning in US

What's happening in the industry

Keytruda gets first-ever biomarker-specific approval read on...

Roche’s VENTANA PD-L1 (SP263) assay gains CE label expansion to inform treatment decisions in lung cancer patients being considered for Keytruda (pembrolizumab) immunotherapy read on...

Leica Biosystems applauds FDA Primary Diagnosis clearance as a step forward in clinical acceptance of digital pathology read on...

Cancer screening firm Guardant Health raises $360 million to sequence tumor DNA of 1 million patients read on...

Thermo Fisher Scientific signs development agreement with Agios Pharmaceuticals for Next-Generation Sequencing oncology companion diagnostic in cholangiocarcinoma read on...

BRAF proficiency testing reporting adequate but could improve, analysis finds read on...

Read More News

What you might have missed

Moving beyond the hype: the reality of NGS in oncology today and in the future
FDA has approved Philips' digital pathology solution as a primary diagnosis tool – it’s about time
156K cancer patients could miss out on life-saving drugs every year in US and Europe
Test availability at launch can be underestimated, under-budgeted and under-resourced: an example using real-time, real world analysis of PD-L1
Personalized Medicine (PM) Connective Announces Achievement of Several Milestones
Realizing the Value of Precision Medicine: Today

Conferences we're attending


2-6 June 2017
Chicago, US

Meet Us

22nd Congress, European Hematology Association

22-25 June 2017
Madrid, Spain

Meet Us

Pharma CIMI Con

26-27 June 2017
Berlin, Germany

Meet Us